Nutrients,
Journal Year:
2024,
Volume and Issue:
16(5), P. 681 - 681
Published: Feb. 28, 2024
Dysbiosis
of
the
microbiota
in
gastrointestinal
tract
can
induce
development
gynaecological
tumours,
particularly
postmenopausal
women,
by
causing
DNA
damage
and
alterations
metabolite
metabolism.
also
complicates
cancer
treatment
influencing
body’s
immune
response
disrupting
sensitivity
to
chemotherapy
drugs.
Therefore,
it
is
crucial
maintain
homeostasis
gut
through
effective
use
food
components
that
affect
its
structure.
Recent
studies
have
shown
polyphenols,
which
are
likely
be
most
important
secondary
metabolites
produced
plants,
exhibit
prebiotic
properties.
They
structure
synthesis
metabolites.
In
this
review,
we
summarise
current
state
knowledge,
focusing
on
impact
polyphenols
endometrial
cancer,
emphasising
polyphenol
consumption
leads
beneficial
modifications
microbiota.
ACS Chemical Neuroscience,
Journal Year:
2023,
Volume and Issue:
14(10), P. 1717 - 1763
Published: May 8, 2023
Gut
microbiota
includes
a
vast
collection
of
microorganisms
residing
within
the
gastrointestinal
tract.
It
is
broadly
recognized
that
gut
and
brain
are
in
constant
bidirectional
communication,
which
its
metabolic
production
major
component,
form
so-called
microbiome–brain
axis.
Disturbances
homeostasis
caused
by
imbalance
their
functional
composition
activities,
known
as
dysbiosis,
cause
dysregulation
these
pathways
trigger
changes
blood–brain
barrier
permeability,
thereby
causing
pathological
malfunctions,
including
neurological
disorders.
In
turn,
can
affect
structure
function
through
autonomic
nervous
system
regulating
motility,
intestinal
transit
secretion,
permeability.
Here,
we
examine
data
from
CAS
Content
Collection,
largest
published
scientific
information,
analyze
publication
landscape
recent
research.
We
review
advances
knowledge
related
to
human
microbiome,
complexity
functionality,
communication
with
central
system,
effect
axis
on
mental
health.
discuss
correlations
between
various
diseases,
specifically
also
explore
metabolites
regard
impact
associated
diseases.
Finally,
assess
clinical
applications
gut-microbiota-related
substances
development
pipelines.
hope
this
serve
useful
resource
understanding
current
emerging
field
an
effort
further
solving
remaining
challenges
fulfilling
potential.
Children,
Journal Year:
2022,
Volume and Issue:
9(7), P. 1014 - 1014
Published: July 8, 2022
The
oral
microbiota
plays
a
vital
role
in
the
human
microbiome
and
health.
Imbalances
between
microbes
their
hosts
can
lead
to
systemic
disorders
such
as
diabetes
or
cardiovascular
disease.
purpose
of
this
review
is
investigate
literature
evidence
dysbiosis
on
health
discuss
current
knowledge
emerging
mechanisms
governing
polymicrobial
synergy
dysbiosis;
both
have
enhanced
our
understanding
pathogenic
aided
design
innovative
therapeutic
approaches
ORALBIOTICA
for
diseases
demineralization.
PubMed,
Web
Science,
Google
Scholar,
Scopus,
Cochrane
Library,
EMBEDDED,
Dentistry
&
Oral
Sciences
Source
via
EBSCO,
APA
PsycINFO,
PsyArticles,
DRUGS@FDA
were
searched
publications
that
matched
topic
from
January
2017
22
April
2022,
with
an
English
language
constraint
using
following
Boolean
keywords:
("microbio*"
"demineralization*")
AND
("oral
microbiota"
"demineralization").
Twenty-two
studies
included
qualitative
analysis.
As
seen
by
review,
balance
unstable
influenced
hygiene,
presence
orthodontic
devices
cavity
poor
eating
habits
modify
its
composition
behavior
positive
negative
ways,
increasing
development
demineralization,
caries
processes,
periodontal
Under
conditions
dysbiosis,
favored
acidic
environment,
reproduction
specific
bacterial
strains
increases,
favoring
cariogenic
ones
Bifidobacterium
dentium,
longum,
World Journal of Gastroenterology,
Journal Year:
2023,
Volume and Issue:
29(28), P. 4368 - 4383
Published: July 26, 2023
The
human
intestine
is
a
natural
environment
ecosystem
of
complex
diversified
and
dynamic
microorganisms,
determined
through
process
competition
selection
during
life.
Those
intestinal
microorganisms
called
microbiota
are
involved
in
variety
mechanisms
the
organism,
they
interact
with
host
therefore
contact
organs
various
systems.
However,
play
crucial
role
maintaining
homeostasis,
also
influencing
its
behaviour.
Thus,
perform
series
biological
functions
important
for
well-being.
provides
nutrients,
simultaneously
drawing
many
benefits
such
as
their
contribution
to
metabolic,
trophic,
immunological,
other
functions.
For
these
reasons
it
has
been
reported
that
quantitative
qualitative
composition
can
protective
or
harmful
on
health.
Therefore,
dysbiosis
lead
an
association
unfavourable
factors
which
dysregulation
physiological
processes
homeostasis.
pre-viously
noted
gut
participate
pathogenesis
autoimmune
diseases,
chronic
inflammation,
diabetes
mellitus,
obesity
atherosclerosis,
neurological
disorders
(e.g.,
autism,
etc.)
colorectal
cancer,
more.
Nutrients,
Journal Year:
2025,
Volume and Issue:
17(2), P. 275 - 275
Published: Jan. 13, 2025
Type
2
diabetes
mellitus
(T2DM),
a
serious
metabolic
disorder,
is
worldwide
health
problem
due
to
the
alarming
rise
in
prevalence
and
elevated
morbidity
mortality.
Chronic
hyperglycemia,
insulin
resistance,
ineffective
effect
secretion
are
hallmarks
of
T2DM,
leading
many
secondary
complications.
These
include,
particular,
cardiovascular
disorders,
diabetic
neuropathy,
nephropathy
retinopathy,
foot,
osteoporosis,
liver
damage,
susceptibility
infections
some
cancers.
Polyphenols
such
as
flavonoids,
phenolic
acids,
stilbenes,
tannins,
lignans
constitute
an
extensive
heterogeneous
group
phytochemicals
fresh
fruits,
vegetables
their
products.
Various
vitro
studies,
animal
model
studies
available
clinical
trials
revealed
that
flavonoids
(e.g.,
quercetin,
kaempferol,
rutin,
epicatechin,
genistein,
daidzein,
anthocyanins),
acids
chlorogenic,
caffeic,
ellagic,
gallic
curcumin),
stilbenes
resveratrol),
tannins
procyanidin
B2,
seaweed
phlorotannins),
pinoresinol)
have
ability
lower
enhance
sensitivity
improve
secretion,
scavenge
reactive
oxygen
species,
reduce
chronic
inflammation,
modulate
gut
microbiota,
alleviate
complications
T2DM.
The
interaction
between
polyphenols
conventional
antidiabetic
drugs
offers
promising
strategy
management
treatment
especially
advanced
disease
stages.
Synergistic
effects
with
been
documented,
but
also
antagonistic
interactions
may
impair
drug
efficacy.
Therefore,
additional
research
required
clarify
mutual
order
use
knowledge
applications.
Nevertheless,
dietary
can
be
successfully
applied
part
supportive
for
they
both
obvious
symptoms
Cureus,
Journal Year:
2023,
Volume and Issue:
unknown
Published: July 8, 2023
The
gut
microbiota
has
been
studied
and
continues
to
be
a
developing
area
in
the
pathognomic
development
of
metabolic
diseases
like
diabetes.
Treatment
with
diet
changes,
addition
supplements
prebiotics/probiotics,
impact
fecal
microbial
transplantation
can
correlated
targeting
changes
dysbiosis.
Understanding
impacts
various
anti-hyperglycemic
agents
such
as
metformin
implications
post-bariatric
surgery
on
diversity
emerged.
These
areas
study
are
crucial
understanding
aspects
diabetes
disease
progression
at
level
inflammatory
mechanisms,
which
may
give
more
insight
into
focusing
role
prebiotic/probiotic
potential
forms
prospective
management
that
target
microbiota,
harbors
low-grade
inflammation.
Intestinal
dysbiosis
was
consistently
observed
mechanism
change
diabetic
individuals,
contributing
reduced
insulin
sensitivity
poor
glycemic
control.
This
systematic
review
carried
out
using
Preferred
Reporting
Items
for
Systematic
Reviews
Meta-analyses
(PRISMA)
2020
checklist.
We
performed
literature
search
PubMed,
Google
Scholar
Science
Direct
databases
accordance
eligibility
criteria
ultimately
selected
14
articles
final
analysis.
Scale
Assessment
Narrative
Review
Articles
(SANRA)
PRISMA
checklist
were
used
assess
quality
cross-sectional
studies,
traditional
reviews,
respectively.
collected
papers
from
2012
2022
this
review.
gathered
databases,
study,
show
there
is
strong
connection
between
appears
exist.
objective
identify
any
dietary
therapeutic
alter
potentially
modulate
sensitivity.
article
will
discuss
pathophysiological
effects
biodiversity
therapeutics
aid
reversing
Pharmaceuticals,
Journal Year:
2024,
Volume and Issue:
17(4), P. 478 - 478
Published: April 8, 2024
Metformin
is
a
synthetic
biguanide
used
as
an
antidiabetic
drug
in
type
2
diabetes
mellitus,
achieved
by
studying
the
bioactive
metabolites
of
Galega
officinalis
L.
It
also
off-label
for
various
other
diseases,
such
subclinical
diabetes,
obesity,
polycystic
ovary
syndrome,
etc.
In
addition,
metformin
proposed
add-on
therapy
several
conditions,
including
autoimmune
neurodegenerative
and
cancer.
Although
has
been
many
decades,
it
still
subject
pharmacodynamic
pharmacokinetic
studies
light
its
extensive
use.
acts
at
mitochondrial
level
inhibiting
respiratory
chain,
thus
increasing
AMP/ATP
ratio
and,
subsequently,
activating
AMP-activated
protein
kinase.
However,
mechanisms
have
proposed,
binding
to
presenilin
enhancer
2,
GLP1
release,
modification
microRNA
expression.
Regarding
pharmacokinetics,
after
oral
administration,
absorbed,
distributed,
eliminated,
mainly
through
renal
route,
using
transporters
cationic
solutes,
since
exists
ionic
molecule
physiological
pH.
this
review,
particular
consideration
paid
literature
data
from
last
10
years,
deepening
study
clinical
trials
inherent
new
uses
metformin,
differences
effectiveness
safety
observed
between
sexes,
unwanted
side
effects.
For
objective,
was
evaluated
both
VigiBase
EudraVigilance,
respectively,
WHO
European
databases
reported
adverse
reactions,
assess
extent
effects
real-life
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(6), P. 3540 - 3540
Published: March 21, 2024
The
intestinal
microbiota
refers
to
the
collection
of
microorganisms
that
exist
in
human
gut.
It
has
been
said
bacteria
influence
development
metabolic
diseases,
such
as
diabetes
mellitus,
they
have
roles
immunomodulation,
protection
against
pathogens,
blood
vessel
growth,
repairing
wall,
and
neurological
system.
In
this
review,
we
look
at
latest
research
regarding
interactions
between
gut
oral
antihyperglycemic
drugs
present
data
suggesting
microbiome
may
help
counteract
reduced
glucose
tolerance
insulin
resistance
associated
with
disorders.
We
found
antidiabetic
can
significant
impacts
on
composition
function,
potentially
influencing
both
efficacy
side
effects
these
medications.
Additionally,
discovered
microbial-based
therapeutics,
including
probiotics,
prebiotics,
postbiotics,
fecal
be
considered
when
discussing
preventive
measures
personalized
treatment
options
for
type
2
mellitus.
Understanding
how
modulate
function
is
essential
optimizing
their
therapeutic
minimizing
potential
adverse
effects.
relationship
glycemic
agents,
not
fully
understood,
currently
subject
increasing
discussion.
proven
impact
effectiveness
medications,
but
further
field
uncover
novel
strategies
other
disorders
by
targeting
microbiota.
Pharmaceuticals,
Journal Year:
2024,
Volume and Issue:
17(4), P. 456 - 456
Published: April 2, 2024
Diabetes
mellitus
(DM)
is
a
common
chronic
metabolic
disease
worldwide.
The
disturbance
of
the
gut
microbiota
has
complex
influence
on
development
DM.
Polysaccharides
are
one
type
most
important
natural
components
with
anti-diabetic
effects.
Gut
can
participate
in
fermentation
polysaccharides,
and
through
this,
polysaccharides
regulate
improve
This
review
begins
by
summary
sources,
effects
regulation
functions
polysaccharides.
Then,
mechanisms
regulating
to
exert
structure–activity
relationship
summarized.
It
found
that
from
plants,
fungi,
marine
organisms
show
great
hypoglycemic
activities
functions.
mainly
include
repairing
burrier,
reshaping
composition,
changing
metabolites,
anti-inflammatory
activity
immune
function,
signal
pathways.
Structural
characteristics
such
as
monosaccharide
molecular
weight,
glycosidic
linkage,
provides
reference
for
exploration